NASDAQ:SNNA - Sienna Biopharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$2.83 -0.10 (-3.41 %)
(As of 01/16/2019 04:00 PM ET)
Previous Close$2.93
Today's Range$2.80 - $3.15
52-Week Range$2.05 - $21.53
Volume182,841 shs
Average Volume334,749 shs
Market Capitalization$61.31 million
P/E Ratio-0.54
Dividend YieldN/A
Beta3.89
Sienna Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of topical products in medical dermatology and aesthetics. The company's lead product candidates include SNA-120, a first-in-class inhibitor of tropomyosin receptor kinase A, which is in a Phase IIb clinical trial for the treatment of pruritus or itch associated with psoriasis, as well as for psoriasis; and SNA-125, a topical janus kinase 3 inhibitor that is in Phase I/II clinical trials for the treatment of atopic dermatitis, psoriasis, and pruritus. It also develops SNA-001, a topical suspension of silver particles, which is in pivotal clinical trials for the treatment of acne, as well as for the reduction of light-pigmented hair, including white, gray, blonde, light brown, and light red hair. The company was formerly known as Sienna Labs, Inc. and changed its name to Sienna Biopharmaceuticals, Inc. in February 2016. Sienna Biopharmaceuticals, Inc. was founded in 2010 and is headquartered in Westlake Village, California.

Receive SNNA News and Ratings via Email

Sign-up to receive the latest news and ratings for SNNA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SNNA
CUSIPN/A
Phone818-629-2256

Debt

Current Ratio4.86
Quick Ratio4.86

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Price / Cash FlowN/A
Book Value$4.44 per share
Price / Book0.64

Profitability

Net Income$-50,540,000.00
Net MarginsN/A
Return on Assets-50.18%

Miscellaneous

Employees47
Market Cap$61.31 million
OptionableNot Optionable

Sienna Biopharmaceuticals (NASDAQ:SNNA) Frequently Asked Questions

What is Sienna Biopharmaceuticals' stock symbol?

Sienna Biopharmaceuticals trades on the NASDAQ under the ticker symbol "SNNA."

How were Sienna Biopharmaceuticals' earnings last quarter?

Sienna Biopharmaceuticals Inc (NASDAQ:SNNA) issued its quarterly earnings results on Thursday, November, 8th. The company reported ($0.82) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.79) by $0.03. View Sienna Biopharmaceuticals' Earnings History.

When is Sienna Biopharmaceuticals' next earnings date?

Sienna Biopharmaceuticals is scheduled to release their next quarterly earnings announcement on Thursday, March 21st 2019. View Earnings Estimates for Sienna Biopharmaceuticals.

What price target have analysts set for SNNA?

2 brokers have issued 12-month price targets for Sienna Biopharmaceuticals' shares. Their predictions range from $17.00 to $45.00. On average, they anticipate Sienna Biopharmaceuticals' stock price to reach $31.00 in the next twelve months. This suggests a possible upside of 995.4% from the stock's current price. View Analyst Price Targets for Sienna Biopharmaceuticals.

What is the consensus analysts' recommendation for Sienna Biopharmaceuticals?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sienna Biopharmaceuticals in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sienna Biopharmaceuticals.

Has Sienna Biopharmaceuticals been receiving favorable news coverage?

Media headlines about SNNA stock have trended somewhat negative on Wednesday, InfoTrie reports. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Sienna Biopharmaceuticals earned a media sentiment score of -1.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the company's share price in the next few days.

Are investors shorting Sienna Biopharmaceuticals?

Sienna Biopharmaceuticals saw a decline in short interest in the month of December. As of December 14th, there was short interest totalling 552,821 shares, a decline of 39.6% from the November 30th total of 915,583 shares. Based on an average daily trading volume, of 224,389 shares, the days-to-cover ratio is presently 2.5 days. Currently, 3.7% of the shares of the stock are sold short. View Sienna Biopharmaceuticals' Current Options Chain.

Who are some of Sienna Biopharmaceuticals' key competitors?

Who are Sienna Biopharmaceuticals' key executives?

Sienna Biopharmaceuticals' management team includes the folowing people:
  • Dr. Frederick C. Beddingfield III, CEO, Pres & Director (Age 54)
  • Mr. John W. Smither, Chief Financial Officer (Age 66)
  • Mr. Majed Kheir, VP of Operations (Age 41)
  • Dr. Silvio Traversa BSc Ph.D., Chief Scientific Officer (Age 49)
  • Mr. Sean Andrews, Sr. Director of Investor Relations

When did Sienna Biopharmaceuticals IPO?

(SNNA) raised $64 million in an initial public offering on Thursday, July 27th 2017. The company issued 4,300,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Cowen and BMO Capital Markets served as the underwriters for the IPO.

How do I buy shares of Sienna Biopharmaceuticals?

Shares of SNNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sienna Biopharmaceuticals' stock price today?

One share of SNNA stock can currently be purchased for approximately $2.83.

How big of a company is Sienna Biopharmaceuticals?

Sienna Biopharmaceuticals has a market capitalization of $61.31 million. The company earns $-50,540,000.00 in net income (profit) each year or ($5.19) on an earnings per share basis. Sienna Biopharmaceuticals employs 47 workers across the globe.

What is Sienna Biopharmaceuticals' official website?

The official website for Sienna Biopharmaceuticals is http://www.siennabio.com.

How can I contact Sienna Biopharmaceuticals?

Sienna Biopharmaceuticals' mailing address is 30699 Russell Ranch Road Suite 140, Westlake Village CA, 91362. The company can be reached via phone at 818-629-2256 or via email at [email protected]


MarketBeat Community Rating for Sienna Biopharmaceuticals (NASDAQ SNNA)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  146 (Vote Outperform)
Underperform Votes:  165 (Vote Underperform)
Total Votes:  311
MarketBeat's community ratings are surveys of what our community members think about Sienna Biopharmaceuticals and other stocks. Vote "Outperform" if you believe SNNA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNNA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/16/2019 by MarketBeat.com Staff

Featured Article: Call Option

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel